![]()
|
Report Date : |
29.01.2008 |
IDENTIFICATION
DETAILS
|
Name : |
CENTRAL MFG CO LTD |
|
|
|
|
Registered Office : |
3-1 Minato Ichikawa City Chiba-Pref 272-0131 |
|
|
|
|
Country : |
Japan |
|
|
|
|
Financials (as on) : |
31.03.2007 |
|
|
|
|
Date of Incorporation : |
December, 1987 |
|
|
|
|
Legal Form : |
Limited Company (Kabushiki Kaisha) |
|
|
|
|
Line of Business : |
Manufacturer of Medical Devices of
Electrocardiogram-Related |
RATING &
COMMENTS
|
MIRA’s Rating : |
B |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Maximum Credit Limit : |
YEN 1.8 Million |
|
|
|
|
Status : |
Moderate |
|
|
|
|
Payment Behaviour : |
Regular |
CENTRAL MFG CO LTD
REGD NAME: Central Kogyo KK
3-1 Minato Ichikawa City Chiba-Pref 272-0131 JAPAN
Tel: 047-399-8181 Fax:
047-399-8182
Mfg of medical devices of electrocardiogram-related
Nil
At the caption address
AKIRA ANDO, PRES
In million Yen, unless otherwise stated
FINANCES R/WEAK A/SALES Yen 100 M
PAYMENTS REGULAR CAPITAL Yen 20 M
TREND SLOW WORTH Yen 90 M
STARTED 1987 EMPLOYES 10
MFR SPECIALIZING IN MEDICAL DEVICES & ACCESSORIES.
FINANCIAL SITUATION CONSIDERED
RATHER WEAK BUT SHOULD BE GOOD FOR MODERATE BUSINESS ENGAGEMENTS.
YEN 1.8 MILLION, 30 DAYS NORMAL TERMS
The subject
company was established by Akira Ando in order to make most of his experience
in the subject line of business.
Specializes in mfg & developing electrocardiogram-related devices
and accessories. Owned and managed by
the Ando family. Clients include
university hospitals.
Financials
are only partially disclosed in rounded-off numbers.
The
sales volume for Mar/2007 fiscal term amounted to Yen 100 million, a similar
amount in the previous term. The net
profit remained similar at Yen 10 million.
For
the current term ending Mar 2008 the net profit is projected at Yen 11 million,
on a 10% rise in turnover, to Yen 110 million.
The
financial situation is considered RATHER WEAK but should be good for MODERATE
business engagements. Max credit limit
is estimated at Yen 1.8 million, on 30 days normal terms.
Date Registered: Dec 1987
Legal Status: Limited
Company (Kabushiki Kaisha)
Authorized: 1,600
shares
Issued: 400
shares
Sum: Yen
20 million
Akira Ando & families
(--100)
Nothing detrimental is known as
to the commercial morality of executives.
Activities: Develops and manufactures medical devices &
supplies (--100%):
Handling items:
Catheter ablation devices for the irregular pulse treatment of heart
disease, RF generator, indeflator, Y-adaptor, torquer & inserter, sheath
& deflator, tissue forceps, operating scissors, needle holders, artery
forceps, other.
[Hospitals, mfrs] Toho
University Hospital, Japan Lifeline, Oshima Medical Ind, Fukuda ME Kogyo,
other.
No. of accounts: 300
Domestic areas of activities: Centered in greater-Tokyo
[Mfrs, wholesalers] Higashi Denki Seisakusho, other.
Payment record: Regular
Location:
Business area in Ichikawa City, Chiba-Pref.
Office premises at the caption address are owned and maintained
satisfactorily.
Chiba Bank (Urayasu)
SMBC (Kasai)
Relations: Satisfactory
FINANCES: (In Million Yen)
|
Terms Ending: |
|
31/03/2008 |
31/03/2007 |
31/03/2006 |
31/03/2005 |
|
Annual Sales |
|
110 |
100 |
100 |
98 |
|
Recur. Profit |
|
|
|
|
|
|
Net Profit |
|
11 |
10 |
10 |
8 |
|
Total Assets |
|
|
N/A |
N/A |
N/A |
|
Net Worth |
|
|
90 |
80 |
70 |
|
Capital, Paid-Up |
|
|
20 |
20 |
20 |
|
Div.P.Share(¥) |
|
|
0.00 |
0.00 |
0.00 |
|
<Analytical Data> |
(%) |
(%) |
(%) |
(%) |
|
|
S.Growth Rate |
10.00 |
0.00 |
2.04 |
-2.00 |
|
|
Current Ratio |
|
|
.. |
.. |
.. |
|
N.Worth Ratio |
|
.. |
.. |
.. |
|
|
N.Profit/Sales |
10.00 |
10.00 |
10.00 |
8.16 |
|
Notes: Financials are only partially disclosed.
Forecast (or estimated) figures for the 31/03/2008 fiscal
term.
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit
consideration. Capability to overcome financial difficulties seems
comparatively below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
NR |
In view of the lack of information, we have no basis upon which to
recommend credit dealings |
No Rating |
|
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)